Should low-risk DCIS lose the cancer label? An evidence review. Ma T, Semsarian CR, Barratt A, Parker L, et al. Breast Cancer Res Treat 2023;199:415-433.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma T, Semsarian CR, Barratt A, Parker L, et al. Should low-risk DCIS lose the cancer label? An evidence review. Breast Cancer Res Treat 2023;199:415-433.
PMID: 37074481